Elanco Animal Health's Upcoming Investor Conference Engagements
Elanco Animal Health Incorporated (NYSE: ELAN) is excited to announce its participation in several prominent investor conferences shortly. These events will offer an excellent opportunity for stakeholders to gain insights into the company’s innovative approaches in the animal health sector and explore emerging trends within the industry.
Key Conference Details and Speaker Engagements
During these conferences, Elanco's management team will highlight the company's initiatives and ongoing commitment to improving animal health. On a significant date, the company's president and CEO, Jeff Simmons, will take part in the BNP Paribas Second Annual Animal Health Day.
Furthermore, another essential engagement will arise on an upcoming date when both Jeff Simmons and Todd Young, the executive vice president and CFO, will participate in a fireside chat during the Stifel 2025 Jaws & Paws Conference. These sessions promise to offer compelling discussions surrounding current industry dynamics and Elanco’s strategic vision.
Webcast Availability for Stakeholders
To ensure that investors and other interested parties can access this dialogue, live audio webcasts of these events will be made available on Elanco's investor website in the Events and Presentations section. Additionally, replays will be provided for a limited period following each event, allowing those unable to attend live discussions to engage with the content at their convenience.
About Elanco Animal Health
With a rich history spanning over 70 years, Elanco Animal Health (NYSE: ELAN) stands as a global leader in enhancing animal health. The organization is dedicated to innovating products and services designed to prevent and treat diseases in both farm animals and pets. Through these efforts, Elanco creates substantial value for agricultural producers, pet owners, veterinarians, and societal stakeholders alike.
Elanco operates under the vision of "Food and Companionship Enriching Life," and through its Elanco Healthy Purpose™ sustainability pillars, the company seeks to advance the well-being of animals while also positively impacting the planet and communities around the globe. Elanco’s ongoing commitment to innovation ensures they remain at the forefront of animal health solutions.
Investor and Media Contacts
For further information or inquiries, investors can reach out to Tiffany Kanaga at (765) 740-0314. Media representatives can contact Colleen Parr Dekker at (317) 989-7011. Their expertise and insights can provide additional clarity on Elanco’s strategies and current initiatives within the animal health industry.
Frequently Asked Questions
What is the purpose of the upcoming investor conferences for Elanco?
The investor conferences aim to provide stakeholders with insights into Elanco’s initiatives and operations in the animal health sector.
Who will represent Elanco at these conferences?
Jeff Simmons, the president and CEO, and Todd Young, the executive vice president and CFO, will represent Elanco at significant events.
Where can I find the webcast of these conferences?
The live audio webcasts will be accessible on Elanco’s investor website in the Events and Presentations section.
How long will the webcasts be available for replay?
Replays of the webcasts will be available for a limited time following each conference.
What is Elanco's mission and vision?
Elanco's mission is to innovate and deliver animal health solutions while its vision emphasizes the importance of food and companionship enriching life.
